Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

Phase I/IIa Study of SAR422459 in Patients With Stargardt’s Macular Degeneration

In this page

Clinical Trial

NCT01367444 Completed
Phase I/IIa Study of SAR422459 in Patients With Stargardt’s Macular Degeneration

Phase I/IIa Study of SAR422459 in Patients With Stargardt’s Macular Degeneration.

Phase 2/1
Interventional

Disease

Disease type

Stargardt Disease

Orphan drug recognition

NA

Patient type

Adult

Children

Inclusion / Exclusion

Opening date

15/05/2011

Closing date

15/05/2019

Inclusion criteria :

More

Exclusion criteria :

More

Funding

industry

Members involved

Main investigators

Pr José-Alain Sahel

France

Genetic Diagnostics (TWG6), Low Vision Daily Life and Patients Groups (TWG5), Neuro-Ophthalmology Rare Diseases (WG2), Pediatric Ophthalmology Rare Diseases (WG3), Registries & Epidemiology (TWG7), Research (TWG8), Retinal Rare Eye Diseases (WG1)
See more

Others investigators

Pr Isabelle Audo

Representative

France

Genetic Diagnostics (TWG6), Low Vision Daily Life and Patients Groups (TWG5), National Integration (TWG9), Neuro-Ophthalmology Rare Diseases (WG2), Pediatric Ophthalmology Rare Diseases (WG3), Registries & Epidemiology (TWG7), Research (TWG8), Retinal Rare Eye Diseases (WG1)
See more

ERN EYE member investigating site

HCP : Principal investigators